Published in Dermatology on January 01, 1995
Oral verrucous carcinoma: a study of 12 cases. Eur J Dent (2010) 1.34
Intra-abdominal localisation of a buschke-lowenstein tumour: case presentation and review of the literature. Case Rep Transplant (2013) 0.80
Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet (1998) 4.72
Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol (1991) 3.29
Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol (1995) 2.37
Heterogeneous bullous pemphigoid antibodies: detection and characterization by immunoblotting when absent by indirect immunofluorescence. J Invest Dermatol (1989) 2.25
Lon-dependent proteolysis of CcdA is the key control for activation of CcdB in plasmid-free segregant bacteria. Mol Microbiol (1994) 2.02
[Survey of post-graduate training for Dermatology and Venereology residents in France (2005-2010)]. Ann Dermatol Venereol (2013) 2.00
Toxicity and feasibility of adjuvant high-dose interferon alpha-2b in patients with melanoma in clinical oncologic practice. Br J Cancer (1999) 1.96
Myeloid transcription factor C/EBPepsilon is involved in the positive regulation of lactoferrin gene expression in neutrophils. Blood (1999) 1.88
Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ (1999) 1.79
Leg ulcers and hydroxyurea: forty-one cases. Arch Dermatol (1999) 1.77
The EPISA study: antimicrobial susceptibility of Staphylococcus aureus causing primary or secondary skin and soft tissue infections in the community in France, the UK and Ireland. J Antimicrob Chemother (2008) 1.75
Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group. Arch Dermatol (1998) 1.70
[Malignant ethmoid bone tumors in woodworkers]. J Med Lyon (1969) 1.68
Calcifying fibrous pseudotumour: first case report in the peritoneum with immunostaining for CD34. Histopathology (1999) 1.63
Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs. J Clin Invest (1986) 1.57
Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. Arch Dermatol (1993) 1.52
Study of the apoptosis induced in vitro by antitumoral drugs on leukaemic cells. Leuk Res (1997) 1.50
Clinical and histological features of head and neck melanoma: a population-based study in France. Br J Dermatol (2015) 1.42
[Does bullous pemphigoid with negative direct immunofluorescence exist? Apropos of 3 cases]. Ann Dermatol Venereol (1992) 1.40
Role of drug exposure in aphthous ulcers: a case-control study. Br J Dermatol (2000) 1.39
The role of general practitioners in diagnosis of cutaneous melanoma: a population-based study in France. Br J Dermatol (2012) 1.39
Cloxacillin versus pristinamycin for superficial pyodermas: a randomized, open-label, non-inferiority study. Dermatology (2005) 1.38
[Haemorrhagic cellulitis: three cases]. Ann Dermatol Venereol (2003) 1.38
Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia (1997) 1.36
Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes. Cytometry (1991) 1.29
A flow cytometric method using Hoechst 33342 and propidium iodide for simultaneous cell cycle analysis and apoptosis determination in unfixed cells. Cytometry (1994) 1.28
CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo. J Pharmacol Exp Ther (1987) 1.24
Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Br J Cancer (2005) 1.24
Intermediate clinical and radiological results of cervical TDR (Mobi-C) with up to 2 years of follow-up. Eur Spine J (2009) 1.23
Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol (1996) 1.23
Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med (1995) 1.21
Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique. Arch Dermatol (1989) 1.21
Analytical methods for thromboxane B2 measurement and validation of radioimmunoassay by gas liquid chromatography-mass spectrometry. Prostaglandins (1978) 1.21
Scorpion toxins: chemistry and mode of action. Adv Cytopharmacol (1979) 1.20
Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring. Clin Chem (1999) 1.20
Comparison between single- and multi-level patients: clinical and radiological outcomes 2 years after cervical disc replacement. Eur Spine J (2011) 1.18
Bier's white spots associated with scleroderma renal crisis. Clin Exp Dermatol (2006) 1.17
Dual-energy CT in the diagnosis and quantification of fatty liver: limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload. J Hepatol (1998) 1.16
Phosphorylation of the respiratory burst oxidase subunit p67(phox) during human neutrophil activation. Regulation by protein kinase C-dependent and independent pathways. J Biol Chem (1997) 1.15
Implication of interleukin-4 in wound healing. Lab Invest (2000) 1.15
Preliminary screening of some tropical plants for anti-tyrosinase activity. J Ethnopharmacol (2002) 1.14
The antidote and autoregulatory functions of the F plasmid CcdA protein: a genetic and biochemical survey. Mol Gen Genet (1994) 1.13
The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index. Br J Urol (1998) 1.13
Intrasinusoidal bone marrow involvement by splenic lymphoma with villous lymphocytes: a helpful immunohistologic feature. Mod Pathol (1997) 1.13
F plasmid CcdB killer protein: ccdB gene mutants coding for non-cytotoxic proteins which retain their regulatory functions. Mol Microbiol (1995) 1.12
High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol (1998) 1.08
Various effects of antidepressant drugs on bone microarchitectecture, mechanical properties and bone remodeling. Toxicol Appl Pharmacol (2007) 1.07
Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma. Br J Dermatol (2006) 1.07
[Historic malignant tumour: 27 observations]. Ann Dermatol Venereol (2011) 1.06
Regulation of nitrogen metabolism is altered in a glnB mutant strain of Rhizobium leguminosarum. Mol Microbiol (1994) 1.05
Clinical polymorphism of cystinosis encephalopathy. Results of treatment with cysteamine. J Inherit Metab Dis (1996) 1.04
Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol (1996) 1.04
Prevalence and characteristics of Sjögren's syndrome or Sicca syndrome in chronic hepatitis C virus infection: a prospective study. J Rheumatol (2001) 1.04
Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukemias with a t(4;12)(q11-q12;p13). Blood (1999) 1.04
Prenatal diagnosis of isolated total anomalous systemic venous return to the coronary sinus. Ultrasound Obstet Gynecol (2010) 1.04
Elevation of IgE in HIV-infected subjects: a marker of poor prognosis. J Allergy Clin Immunol (1992) 1.02
Aortic angiosarcoma clinically mimicking polyarteritis nodosa. Scand J Rheumatol (2006) 1.02
Prenatal diagnosis of human cytomegalovirus by culture and polymerase chain reaction: 98 pregnancies leading to congenital infection. Prenat Diagn (1999) 1.01
How to recognize and workaround pitfalls in QSAR studies: a critical review. Curr Med Chem (2009) 1.01
Determinants of persistent detection of human papillomavirus DNA in the uterine cervix. J Infect Dis (1996) 1.01
D-dimer strategy in thrombosis exclusion--a gold standard study in 100 patients suspected of deep venous thrombosis or pulmonary embolism: 8 DD methods compared. Thromb Haemost (1998) 1.01
Aphid biology: expressed genes from alate Toxoptera citricida, the brown citrus aphid. J Insect Sci (2003) 1.01
Cumulative influence of matrix metalloproteinase-1 and -2 in the migration of melanoma cells within three-dimensional type I collagen lattices. Exp Cell Res (2001) 0.99
Onychomatricoma with misleading features. Acta Derm Venereol (2001) 0.99
Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida. J Invest Dermatol (1997) 0.99
Dermatomyositis and malignancy. J Invest Dermatol (1993) 0.98
Congenital solitary histiocytoma: a variant of Hashimoto-Pritzker histiocytosis. A retrospective study of 8 cases. Dermatology (2008) 0.98
MRI of paraganglioma of the filum terminale. J Comput Assist Tomogr (1996) 0.97
[Giant buccal aphthosis caused by nicorandil]. Presse Med (1997) 0.96
Multicenter randomized evaluation of a nutritional education software in obese patients. Diabetes Metab (2001) 0.96
Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis. Arch Dermatol (1990) 0.96
Expression of REG protein during cell growth and differentiation of two human colon carcinoma cell lines. J Histochem Cytochem (1999) 0.96
Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions. Br J Dermatol (2004) 0.96
p53 and c-erbB-2 as markers of resistance to adjuvant chemotherapy in breast cancer. Mod Pathol (1998) 0.96
[Post-traumatic acral melanoma: an underestimated reality?]. Ann Dermatol Venereol (2012) 0.96
[Dermatitis artefacta: retrospective study in 31 patients]. Ann Dermatol Venereol (2006) 0.96
Anti-inflammatory drugs and variceal bleeding: a case-control study. Gut (1999) 0.96
[Goldmann-Favre hyaloido-tapeto-retinal degeneration. Apropos of a case]. Bull Mem Soc Fr Ophtalmol (1973) 0.95
Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera. Dermatology (2004) 0.95
Early transitory rise in intracellular pH leads to Bax conformation change during ceramide-induced apoptosis. Apoptosis (2000) 0.95
Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group. Leukemia (1995) 0.94
Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia. Exp Hematol (1986) 0.94
Expression of c-Myc, neurofibromatosis Type 2, somatostatin receptor 2 and erb-B2 in human meningiomas: relation to grades or histotypes. Clin Neuropathol (2008) 0.93
[Anticytoplasmic antibodies of human epidermal cells (author's transl)]. Ann Dermatol Venereol (1977) 0.93
P40phox associates with the neutrophil Triton X-100-insoluble cytoskeletal fraction and PMA-activated membrane skeleton: a comparative study with P67phox and P47phox. J Leukoc Biol (1999) 0.93
Melorheostosis with associated minimal change nephrotic syndrome, mesenteric fibromatosis and capillary haemangiomas. Dermatology (1994) 0.93
Response at three months is a good predictive factor for newly diagnosed chronic myeloid leukemia patients treated by recombinant interferon-alpha. Blood (1998) 0.93
Automated reticulocyte counting and immature reticulocyte fraction measurement. Comparison of ABX PENTRA 120 Retic, Sysmex R-2000, flow cytometry, and manual counts. Am J Clin Pathol (1999) 0.92
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. Ann Oncol (2011) 0.92
Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myeloma. J Clin Oncol (1996) 0.92